Varadan Sevilimedu
Overview
Explore the profile of Varadan Sevilimedu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
114
Citations
744
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perry L, Sevilimedu V, Polidorio N, Abuhadra N, Morrow M, Plitas G, et al.
Ann Surg Oncol
. 2025 Mar;
PMID: 40025324
Background: The combination of pembrolizumab with neoadjuvant chemotherapy (NAC) for triple-negative breast cancer (TNBC) improves pathologic complete response (pCR) rates and event-free survival. Yet it is unclear which patients benefit...
2.
Tadros A, Diskin B, Sevilimedu V, Xu A, Vingan P, Nelson J, et al.
JAMA Netw Open
. 2025 Feb;
8(2):e2454506.
PMID: 40009385
Importance: Inflammatory breast cancer (IBC) is an aggressive variant for which trimodality treatment (ie, neoadjuvant systemic therapy [NST] followed by modified radical mastectomy without immediate reconstruction and postmastectomy radiotherapy [PMRT])...
3.
Roberts A, Campbell A, Pollack B, Montagna G, Sevilimedu V, Axelrod B, et al.
Ann Surg Oncol
. 2025 Feb;
PMID: 39971857
Background: Chronic inflammatory responses initiated by lymphatic injury play a key role in the pathophysiology of secondary lymphedema; however, it is unknown if these responses vary by race/ethnicity. We assessed...
4.
Amir T, Coffey K, Reiner J, Sevilimedu V, Mango V
Ultrasonography
. 2025 Feb;
44(2):145-152.
PMID: 39967448
Purpose: This study aimed to evaluate our institution's experience in using artificial intelligence (AI) decision support (DS) as part of the clinical workflow to triage patients with Breast Imaging Reporting...
5.
Nissan N, Sevilimedu V, Gluskin J, Arita Y, Keating D, DAlessio D, et al.
Radiology
. 2025 Feb;
314(2):e241158.
PMID: 39932415
Background Background parenchymal enhancement (BPE) is an important diagnostic and prognostic imaging biomarker. Although hormonal regulation of BPE at breast MRI has been investigated, information regarding hormonal regulation of BPE...
6.
Long N, Woodlock D, DAgostino R, Nguyen G, Gangai N, Sevilimedu V, et al.
Cancers (Basel)
. 2025 Jan;
17(2).
PMID: 39858000
Background/objectives: Improved survival due to advances in medical therapy has resulted in increasing numbers of cancer patients living with bone metastases; however, our understanding of the prognostic implications of bone...
7.
Simmons A, Han L, Reiner J, Mango V, Sevilimedu V, Pinker K, et al.
Radiol Imaging Cancer
. 2024 Nov;
6(6):e240010.
PMID: 39513941
Purpose To evaluate racial disparities in preoperative breast MRI use and surgical margin outcomes among patients with recently diagnosed breast cancer. Materials and Methods This retrospective study included patients with...
8.
Montagna G, Laws A, Ferrucci M, Mrdutt M, Sun S, Bademler S, et al.
J Clin Oncol
. 2024 Nov;
43(7):810-820.
PMID: 39509672
Purpose: The nodal burden of patients with residual isolated tumor cells (ITCs) in the sentinel lymph nodes (SLNs) after neoadjuvant chemotherapy (NAC) (ypN0i+) is unknown, and axillary management is not...
9.
Matar-Ujvary R, Sevilimedu V, Morrow M
Ann Surg Oncol
. 2024 Nov;
32(1):125-126.
PMID: 39500860
No abstract available.
10.
Matar-Ujvary R, Sevilimedu V, Morrow M
Ann Surg Oncol
. 2024 Oct;
32(1):92-97.
PMID: 39394489
Background: Whether cN0 patients with image-detected nodal metastases are appropriate for sentinel lymph node biopsy (SLNB) or should proceed directly to axillary lymph node dissection (ALND) or neoadjuvant chemotherapy (NAC)...